Drug-Drug Interaction Study of Evobrutinib and Transporter Substrates

Conditions

• Healthy

Interventions

• DRUG: Evobrutinib (45mg)
• DRUG: Digoxin (0.25mg)
• DRUG: Metformin (10mg)
• DRUG: Rosuvastatin (10mg)
• DRUG: Sumatriptan (25mg)

Sponsor

Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany